Intra-arterial infusion of fasudil hydrochloride for treating vasospasm following subarachnoid haemorrhage

Acta Neurochirurgica

Volumn 141, Issue 1, 1999, Pages 13-19

  Tachibana, E ^a   Harada, T ^b   Shibuya, M ^c   Saito, Kiyoshi ^a   Takayasu, M ^a   Suzuki, Y ^a   Yoshida, J ^a  

^a NAGOYA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b KASUGAI MUNICIPAL HOSPITAL   (Japan)

^c CHUKYO HOSPITAL   (Japan)

Author keywords

Cerebral vasospasm; Fasudil hydrochloride; Intra arterial infusion; Subarachnoid haemorrhage

Indexed keywords

FASUDIL;

ADULT; AGED; ANGIOGRAPHY; ARTICLE; BRAIN INFARCTION; CLINICAL ARTICLE; CLINICAL TRIAL; FEMALE; HUMAN; INTERNAL CAROTID ARTERY; INTRAARTERIAL DRUG ADMINISTRATION; MALE; PILOT STUDY; PRIORITY JOURNAL; SUBARACHNOID HEMORRHAGE; VASOSPASM; VERTEBRAL ARTERY;

1-(5-ISOQUINOLINESULFONYL)-2-METHYLPIPERAZINE; ADULT; AGED; ANEURYSM, RUPTURED; FEMALE; HUMANS; INFUSIONS, INTRA-ARTERIAL; INTRACRANIAL ANEURYSM; ISCHEMIC ATTACK, TRANSIENT; MALE; MIDDLE AGED; PILOT PROJECTS; SUBARACHNOID HEMORRHAGE; TREATMENT OUTCOME; VASODILATOR AGENTS;

EID: 0032894607     PISSN: 00016268     EISSN: None     Source Type: Journal    
DOI: 10.1007/s007010050260     Document Type: Article

References (21)

1. 1. Adams HP Jr, Kassell NF, Torner JC, Haley EC Jr (1987) Predicting cerebral ischemia after aneurysmal subarachnoid hemorrhage: influence of clinical condition, CT results, and antifibrinolytic therapy. A report of the cooperative aneurysmal study. Neurology 37: 1586-1591
2. 2. Asano T, Ikegaki I, Satoh S, Suzuki Y, Shibuya M, Takayasu M, Hidaka H (1987) Mechanism of action of a novel antivasospasm drug, HA1077. J Pharmacol Exp Ther 241: 1033-1040
3. 3. Asano T, Suzuki T, Tsuchiya M, Satoh S, Ikegaki I, Suzuki Y, Hidaka H (1989) Vasodilator actions of HA 1077 in vitro and in vivo putatively mediated by the inhibition of protein kinase. Br J Pharmacol 98: 1091-1100
4. 4. Haley EC Jr, Kassell NF, Apperson-Hansen C, Maile MH, Alves WM (1997) A randomized, double-blind, vehicle-controlled trial of tiriazad mesylate in patients with aneurysmal subarachnoid hemorrhage: a cooperative study in North America. J Neurosurg 86: 467-474
5. 5. Hendrix LE, Dion JE, Jensen ME, Phillips CD, Newman SA (1994) Papaverine-induced mydriasis. AJNR 15: 716-718
6. 6. Higashida RT, Halbach VV, Cahan LD, Brant-Zawadzki M, Barnwell S, Dowd C, Hieshima GB (1989) Transluminal angioplasty for treatment of intracranial arterial vasospasm. J Neurosurg 71: 648-653
7. 7. Kaku Y, Yonekawa Y, Tsukahara T, Kazekawa K (1992) Superselective intra-arterial infusion of papaverine for the treatment of cerebral vasospasm after subarachnoid hemorrhage. J Neurosurg 77: 842-847
8. 8. Kassell NF, Helm G, Simmons N, Phillips CD, Cail WS (1992) Treatment of cerebral vasospasm with intra-arterial papaverine. J Neurosurg 77: 848-852
9. 9. Kassell NF, Haley EC Jr, Apperson-Hansen C, Alves WM (1996) Randomized, double-blind, vehicle-controlled trial of tiriazad mesylate in patients with aneurysmal subarachnoid hemorrhage: a cooperative study in Europe, Australia, and New Zealand. J Neurosurg 84: 221-228
10. 10. Linskey ME, Horton JA, Rao GR, Yonas H (1991) Fatal rupture of the intracranial carotid artery during transluminal angioplasty for vasospasm induced by subarachnoid hemorrhage. J Neurosurg 74: 985-990
11. 11. Mayberg MR Intracranial arterial spasm. In: Wilkins RH et al (eds) Neurosurgery, vol 2. McGraw-Hill, New York, pp 2245-2254
12. 12. McAuliffe W, Townsend M, Eskridge J, Newell DW, Grady MS, Winn HR (1995) Intracranial pressure changes induced during papaverine infusion for treatment of vasospasm. J Neurosurg 83: 430-434
13. 13. Miller JA, Cross DT, Moran CJ, Dacey RG Jr, McFarland JD, Diringer MN (1995) Severe thrombocytopenia following intraarterial papaverine administration for treatment of vasospasm. J Neurosurg 83: 435-437
14. 14. Naka M, Kureishi Y, Muroga Y, Takahashi K, Ito M, Tanaka T (1990) Modulation of smooth muscle calponin by protein kinase C and calmodulin. Biochem Biophys Res Commun 171: 933-937
15. 15. Ohkawa M, Fujiwara N, Tanabe M, Takashima H, Satoh K, Kojima K, Irie K, Honjo Y, Nagao S (1996) Cerebral vasospastic vessels: histologic changes after percutaneous transluminal angioplasty. Radiology 198: 179-184
16. 16. Origitano TC, Wascher TM, Reichman OH, Anderson DE (1990) Sustained increased cerebral blood flow with prophylactic hypertensive hypervolemic hemodilution ("triple-H" therapy) after subarachnoid hemorrhage. Neurosurgery 27: 729-740
17. 17. Seto M, Shindo K, Ito K, Sasaki Y (1995) Selective inhibition of myosin phosphorylation and tension of hyperplastic arteries by the kinase inhibitor HA1077. Eur J Pharmacol 276: 27-33
18. 18. Shibuya M, Suzuki Y, Takayasu M, Asano T, Harada T, Ikegaki I, Satoh S, Hidaka H (1988) The effect of an intracellular calcium antagonist HA 1077 on delayed cerebral vasospasm in dogs. Acta Neurochir (Wien) 90: 53-59
19. 19. Shibuya M, Suzuki Y, Sugita K, Saito I, Takakura K, Okamoto S, Kikuchi H, Takemae T, Hidaka H (1990) Dose escalation trial of a novel calcium antagonist, AT877, in patients with aneurysmal subarachnoid haemorrhage. Acta Neurochir (Wien) 107: 11-15
20. 20. Shibuya M, Suzuki Y, Sugita K, Saito I, Sasaki T, Takakura K, Nagata I, Kikuchi H, Takemae T, Hidaka H, Nakashima M (1992) Effect of AT877 on cerebral vasospasm after aneurysmal subarachnoid hemorrhage. J Neurosurg 76: 571-577
21. 21. Takayasu M, Suzuki Y, Shibuya M, Asano T, Kanamori M, Okada T, Kageyama N, Hidaka H (1986) The effect of HA compound calcium antagonists on delayed cerebral vasospasm in dogs. J Neurosurg 65: 80-85